Clinical Trial Update: Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors [Phase 1]

View source ↗

Summary

Phase 1 evaluation of vorinostat in combination with temozolomide in children with relapsed or refractory primary brain tumors or spinal cord tumors has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Teratoid Rhabdoid Tumor
• Central Nervous System Germinoma
• Craniopharyngioma
• Ependymoma
• High-grade Cerebellar Astrocytoma
• High-grade Cerebral Astrocytoma
• Medulloblastoma
• Oligodendroglioma

Drugs mentioned

• Temozolomide (Temozolomide)
• Vorinostat (vorinostat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Central Nervous System Choriocarcinoma | Phase 1 | Status: COMPLETED